Design Therapeutics, Inc.

Q3 2022 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
81
Total reported value, excl. options
$667M
Manager Report Date Value ($000) Shares